A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Using repaglinide (NovoNorm) in the Treatment of Type 2 Diabetic Patients in Routine Clinical Practice.
Latest Information Update: 04 Nov 2016
Price :
$35 *
At a glance
- Drugs Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 29 Dec 2011 New trial record